Related Experiment Video
Updated: May 10, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Novel variants require established frameworks: emphasizing the role of ISTH diagnostic and classification guidelines
1Unit for Thrombosis Research, Department of Regional Health Science, University of Southern Denmark, Esbjerg,, Denmark. vakur.bor@rsyd.dk.
Insights
This commentary emphasizes using International Society on Thrombosis and Haemostasis (ISTH) guidelines and bleeding assessment tools for diagnosing congenital fibrinogen disorders. Standardized methods improve the evaluation of these rare conditions.
Area of Science:
- Hematology
- Clinical Diagnostics
- Rare Diseases
Background:
- Congenital fibrinogen disorders are rare bleeding conditions.
- Accurate diagnosis is crucial for patient management.
- Current diagnostic approaches may lack standardization.
Abstract:
This commentary aims to highlight the importance of applying the diagnostic and classification guidelines of the International Society on Thrombosis and Haemostasis (ISTH), along with standardized bleeding assessment tools, in the evaluation of patients with congenital fibrinogen disorders. Additionally, it addresses key laboratory methodologies relevant to the diagnosis of these conditions. We believe that this commentary will contribute meaningfully to the ongoing discussions and promote the adoption of standardized approaches in the assessment of rare congenital fibrinogen disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

